Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial Suzana Margareth Lobo , Gaétan Plantefève , Girish Nair , Adilson Joaquim Cavalcante , Nara Franzin de Moraes , Estevao Nunes , Otis Barnum , Claudio Marcel Berdun Stadnik , Maria Patelli Lima , Muriel Lins , Ludhmila Abrahao Hajjar , Christopher Lipinski , Shaheen Islam , Fabiano Ramos , Tiago Simon , Jean-Benoît Martinot , Thomas Guimard , Arnaud Desclaux , Bertrand Lioger , Fernando Carvalho Neuenschwander eClinicalMedicine（2024）
关键词
SARS-CoV-2, COVID-19, Renin-angiotensin-system (RAS), MasR, 20-Hydroxyecdysone, Respiratory failure
AI 理解论文
溯源树
样例
